Citations (3)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Andreas Katsanos, Ivano Riva, Banu Bozkurt, Gábor Holló, Luciano Quaranta, Francesco Oddone, Murat Irkec, Gordon N. Dutton & Anastasios G. Konstas. (2022) A new look at the safety and tolerability of prostaglandin analogue eyedrops in glaucoma and ocular hypertension. Expert Opinion on Drug Safety 21:4, pages 525-539.
Read now
Read now
Articles from other publishers (2)
Tao Wang, Yunran Zhang, Meiling Chi, Chen Zhao, Linlin Cao, Chutong Tian, K. Kamei, Ying Zheng & Qikun Jiang. (2022) A novel fixed-combination timolol-netarsudil-latanoprost ophthalmic solution for the treatment of glaucoma and ocular hypertension. Asian Journal of Pharmaceutical Sciences 17:6, pages 938-948.
Crossref
Crossref
Javier F. Casiraghi, Daniel Grigera, J. Alejo Peyret, Melina del Papa & María Silvia Passerini. (2021) Efficacy and Tolerability of a New Latanoprost 0.005% BAK-Free Nanoemulsion: A Nonrandomized Open-Label Trial. Re:GEN Open 1:1, pages 110-116.
Crossref
Crossref